CoV-GLUEGenomeCountriesLineagesMutationsInsertionsDeletionsUpdated:

CoV-GLUE | Mutations | Mutation

CoV-GLUE Mutation: ORF = ORF1ab/nsp16 : Mut = D133N

Details of the codons used for the mutation across all lineages (CodonProp is the proportion each codon is used for this AA mutation):

ORFCodonNumMutORF1abMutMutTypeRefCodonMutCodonAACountCodonCountCodonPropGenome Position
ORF1ab/nsp16133D133ND6931NnonsynGacAac21372137121055-21057

Details of the mutation D133N within lineages (LineageCodonProp is the proportion the codon is observed at, at this particular site, on each lineage):

ORFCodonNumMutRefCodonMutCodonCodonCountAACountLineageLineageCodonProp
ORF1ab/nsp16133D133NGacAac21372137All0.000409
ORF1ab/nsp16133D133NGacAac15901590AY.30.015815
ORF1ab/nsp16133D133NGacAac183183AY.40.000285
ORF1ab/nsp16133D133NGacAac6060B.1.1.70.000054
ORF1ab/nsp16133D133NGacAac5050AY.250.000301
ORF1ab/nsp16133D133NGacAac2222B.1.617.20.000083
ORF1ab/nsp16133D133NGacAac1313AY.1030.000081
ORF1ab/nsp16133D133NGacAac1212AY.430.000053
ORF1ab/nsp16133D133NGacAac1212B.1.1770.000158
ORF1ab/nsp16133D133NGacAac1111AY.3.10.000938
ORF1ab/nsp16133D133NGacAac1010B.1.10.000181
ORF1ab/nsp16133D133NGacAac1010B.1.20.000088
ORF1ab/nsp16133D133NGacAac1010B.1.2650.012706
ORF1ab/nsp16133D133NGacAac99AY.440.000055
ORF1ab/nsp16133D133NGacAac88AE.80.003912
ORF1ab/nsp16133D133NGacAac88AY.390.000198
ORF1ab/nsp16133D133NGacAac77B.10.000064
ORF1ab/nsp16133D133NGacAac66AY.50.000124
ORF1ab/nsp16133D133NGacAac66B.1.177.730.003398
ORF1ab/nsp16133D133NGacAac66P.10.000095
ORF1ab/nsp16133D133NGacAac55AY.470.000156
ORF1ab/nsp16133D133NGacAac44AY.1170.000338
ORF1ab/nsp16133D133NGacAac44AY.540.000381
ORF1ab/nsp16133D133NGacAac44AY.710.0019
ORF1ab/nsp16133D133NGacAac44AY.99.20.000369
ORF1ab/nsp16133D133NGacAac44B.1.1.2220.000816
ORF1ab/nsp16133D133NGacAac44B.1.2580.000266
ORF1ab/nsp16133D133NGacAac44B.1.4290.000094
ORF1ab/nsp16133D133NGacAac33AY.1160.00086
ORF1ab/nsp16133D133NGacAac33AY.1190.000106
ORF1ab/nsp16133D133NGacAac33AY.290.000047
ORF1ab/nsp16133D133NGacAac33B0.000383
ORF1ab/nsp16133D133NGacAac33B.1.2210.000213
ORF1ab/nsp16133D133NGacAac22AY.1020.000053
ORF1ab/nsp16133D133NGacAac22AY.1050.001286
ORF1ab/nsp16133D133NGacAac22AY.1180.000125
ORF1ab/nsp16133D133NGacAac22AY.120.000632
ORF1ab/nsp16133D133NGacAac22AY.230.000139
ORF1ab/nsp16133D133NGacAac22AY.260.000057
ORF1ab/nsp16133D133NGacAac22AY.460.000208
ORF1ab/nsp16133D133NGacAac22AY.920.000575
ORF1ab/nsp16133D133NGacAac22B.1.1.250.001137
ORF1ab/nsp16133D133NGacAac22B.1.1.3060.000877
ORF1ab/nsp16133D133NGacAac22B.1.160.260.004843
ORF1ab/nsp16133D133NGacAac22B.1.2430.000139
ORF1ab/nsp16133D133NGacAac22B.1.3510.000059
ORF1ab/nsp16133D133NGacAac22B.1.351.30.001753
ORF1ab/nsp16133D133NGacAac22B.1.4260.002018
ORF1ab/nsp16133D133NGacAac22B.1.4270.000101
ORF1ab/nsp16133D133NGacAac110.055556
ORF1ab/nsp16133D133NGacAac11AY.200.000039
ORF1ab/nsp16133D133NGacAac11AY.270.000065
ORF1ab/nsp16133D133NGacAac11AY.330.000067
ORF1ab/nsp16133D133NGacAac11AY.350.000233
ORF1ab/nsp16133D133NGacAac11AY.39.10.00004
ORF1ab/nsp16133D133NGacAac11AY.420.00004
ORF1ab/nsp16133D133NGacAac11AY.450.000122
ORF1ab/nsp16133D133NGacAac11AY.680.000274
ORF1ab/nsp16133D133NGacAac11AY.75.10.00018
ORF1ab/nsp16133D133NGacAac11AY.840.000437
ORF1ab/nsp16133D133NGacAac11AY.980.000079
ORF1ab/nsp16133D133NGacAac11B.1.1.5190.00004
ORF1ab/nsp16133D133NGacAac11B.1.110.30.000718
ORF1ab/nsp16133D133NGacAac11B.1.1600.000031
ORF1ab/nsp16133D133NGacAac11B.1.36.120.009615
ORF1ab/nsp16133D133NGacAac11B.1.36.170.000494
ORF1ab/nsp16133D133NGacAac11B.1.36.190.009259
ORF1ab/nsp16133D133NGacAac11B.1.416.10.001563
ORF1ab/nsp16133D133NGacAac11B.1.466.20.000391
ORF1ab/nsp16133D133NGacAac11B.1.6090.000479
ORF1ab/nsp16133D133NGacAac11B.1.6250.002353
ORF1ab/nsp16133D133NGacAac11P.1.120.000484
ORF1ab/nsp16133D133NGacAac11P.1.140.000048

CoV-GLUE is still in development. CoV-GLUE was originally developed as part of COG-UK by Josh Singer using the GLUE framework at the MRC-University of Glasgow Centre for Virus Research (CVR). In 2021 it was redeveloped by Richard Orton to scale to the millions of genome sequences available. We acknowledge support from the MRC (MC_UU_12014/12), WT (220977/Z/20/Z) and UKRI G2P (MR/W005611/1). Please contact Richard Orton with any queries: Richard.Orton@glasgow.ac.uk

CoV-GLUE uses sequence data from GISAID. GISAID data provided via this web application is subject to GISAID's Terms and Conditions.